Durect Corporation Announces Outcome of FDA Advisory Committee Meeting for Posimir
CUPERTINO, Calif., Jan. 17, 2020 /PRNewswire/ -- Durect Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration ' s (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) met yesterday to discuss the...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Anesthesia | Anesthesiology | Clinical Trials | Food and Drug Administration (FDA) | Pharmaceuticals